标题
Treatment of Mild, Moderate, and Severe Lupus Erythematosus: Focus on New Therapies
作者
关键词
-
出版物
Current Rheumatology Reports
Volume 13, Issue 4, Pages 308-316
出版商
Springer Nature
发表日期
2011-05-16
DOI
10.1007/s11926-011-0186-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
- (2010) P. M. Izmirly et al. ANNALS OF THE RHEUMATIC DISEASES
- Thrombovascular events in systemic lupus erythematosus: Comment on the article by Jung et al
- (2010) Daniel J. Wallace ARTHRITIS AND RHEUMATISM
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Off-label use of rituximab in systemic lupus erythematosus: a systematic review
- (2010) Eleanor Murray et al. CLINICAL RHEUMATOLOGY
- B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor
- (2010) Fabienne Mackay et al. IMMUNOLOGICAL REVIEWS
- Interferon Alpha in Systemic Lupus Erythematosus
- (2010) Timothy B. Niewold et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus
- (2010) Mary K. Crow RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus
- (2010) Frederick Wolfe et al. ARTHRITIS CARE & RESEARCH
- Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus
- (2009) Yihong Yao et al. ARTHRITIS AND RHEUMATISM
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
- (2009) Jai Radhakrishnan et al. KIDNEY INTERNATIONAL
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
- (2009) David Isenberg et al. RHEUMATOLOGY
- Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies
- (2008) L. H. Calabrese et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
- (2008) Richard Furie et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More